New eye drug trial aims to save sight in Hard-to-Treat AMD
Disease control
Not yet recruiting
This study tests faricimab, a drug injected into the eye, for people with type 3 wet age-related macular degeneration (AMD), a condition that can cause rapid vision loss. Over 76 weeks, 30 participants will receive initial monthly doses, then a personalized schedule where injecti…
Phase: PHASE4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC